Faithward Advisors’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$56.1K	–	311
2025 Q4	$56.1K	Hold	30,000	–	–	0.01%	326
2025 Q3	$38.4K	Hold	30,000	–	–	0.01%	303
2025 Q2	$37.2K	Hold	30,000	–	–	0.01%	264
2025 Q1	$35.4K	Hold	30,000	–	–	0.01%	259
2024 Q4	$54.9K	Hold	30,000	–	–	0.01%	251
2024 Q3	$51K	Hold	30,000	–	–	0.01%	278
2024 Q2	$41.1K	Hold	30,000	–	–	0.01%	250
2024 Q1	$113K	Hold	30,000	–	–	0.02%	249
2023 Q4	$193K	Buy	30,000 +7,000	+30%	+$57.2K	0.04%	166
2023 Q3	$148K	Buy	23,000 +4,000	+21%	+$45.7K	0.04%	162
2023 Q2	$219K	Buy	19,000 +1,000	+6%	+$12.2K	0.05%	158
2023 Q1	$219K	Hold	18,000	–	–	0.05%	173
2022 Q4	$147K	Hold	18,000	–	–	0.03%	151
2022 Q3	$104K	Hold	18,000	–	–	0.02%	144
2022 Q2	$80K	Hold	18,000	–	–	0.02%	170
2022 Q1	$164K	Buy	18,000 +5,000	+38%	+$57.6K	0.03%	163
2021 Q4	$266K	Sell	13,000 -7,500	-37%	-$181K	0.05%	140
2021 Q3	$524K	Buy	20,500 +9,500	+86%	+$281K	0.1%	102
2021 Q2	$385K	Buy	+11,000	New	+$320K	0.08%	116
2021 Q1	–	Sell	-11,000	Closed	-$285K	–	254
2020 Q4	$285K	Sell	11,000 -11,500	-51%	-$195K	0.12%	67
2020 Q3	$222K	Buy	+22,500	New	+$130K	0.05%	127